Screening of Chemical Libraries Using a Yeast Model of Retinal Disease
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Screening of Chemical Libraries Using a Yeast Model of Retinal Disease
Authors
Keywords
-
Journal
SLAS Discovery
Volume -, Issue -, Pages 247255521987593
Publisher
SAGE Publications
Online
2019-09-27
DOI
10.1177/2472555219875934
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ligand channel in pharmacologically stabilized rhodopsin
- (2018) Daniel Mattle et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential strategies for therapy
- (2018) Dimitra Athanasiou et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Coupling of Human Rhodopsin to a Yeast Signaling Pathway Enables Characterization of Mutations Associated with Retinal Disease
- (2018) Benjamin M. Scott et al. GENETICS
- The role of the ER stress-response protein PERK in rhodopsin retinitis pigmentosa
- (2017) Dimitra Athanasiou et al. HUMAN MOLECULAR GENETICS
- Pharmacological chaperone approaches for rescuing GPCR mutants: Current state, challenges, and screening strategies
- (2017) Pieter Beerepoot et al. PHARMACOLOGICAL RESEARCH
- Receptor antagonism/agonism can be uncoupled from pharmacoperone activity
- (2016) Jo Ann Janovick et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Pharmacological approaches to retinitis pigmentosa: A laboratory perspective
- (2015) Viviana Guadagni et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Assay strategies for identification of therapeutic leads that target protein trafficking
- (2015) P. Michael Conn et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- A Highly Characterized Yeast Toolkit for Modular, Multipart Assembly
- (2015) Michael E. Lee et al. ACS Synthetic Biology
- A Phenotypic High Throughput Screening Assay for the Identification of Pharmacoperones for the Gonadotropin Releasing Hormone Receptor
- (2014) P. Michael Conn et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- Inherent Instability of the Retinitis Pigmentosa P23H Mutant Opsin
- (2014) Yuanyuan Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Challenges using diagnostic next-generation sequencing in the clinical environment for inherited retinal disorders
- (2014) Wayne IL Davies Personalized Medicine
- Retinitis Pigmentosa Mutants Provide Insight into the Role of the N-terminal Cap in Rhodopsin Folding, Structure, and Function
- (2013) Chikwado A. Opefi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- High-Throughput Screening for Growth Inhibitors Using a Yeast Model of Familial Paraganglioma
- (2013) Irina Bancos et al. PLoS One
- Yeast Reveal a "Druggable" Rsp5/Nedd4 Network that Ameliorates -Synuclein Toxicity in Neurons
- (2013) D. F. Tardiff et al. SCIENCE
- Treatment With 9-cisβ-Carotene–Rich Powder in Patients With Retinitis Pigmentosa
- (2013) Ygal Rotenstreich et al. JAMA Ophthalmology
- Rhodopsin Mutant P23H Destabilizes Rod Photoreceptor Disk Membranes
- (2012) Mohammad Haeri et al. PLoS One
- Rhodopsin Gene Expression Determines Rod Outer Segment Size and Rod Cell Resistance to a Dominant-Negative Neurodegeneration Mutant
- (2012) Brandee A. Price et al. PLoS One
- Clinical Trial of Lutein in Patients With Retinitis Pigmentosa Receiving Vitamin A
- (2010) ARCHIVES OF OPHTHALMOLOGY
- A yeast-based genomic strategy highlights the cell protein networks altered by FTase inhibitor peptidomimetics
- (2010) Giampiero Porcu et al. Molecular Cancer
- Pharmacological manipulation of gain-of-function and dominant-negative mechanisms in rhodopsin retinitis pigmentosa
- (2008) Hugo F. Mendes et al. HUMAN MOLECULAR GENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation